113 related articles for article (PubMed ID: 23175171)
1. Photodynamic therapy for bile duct invasion of hepatocellular carcinoma.
Bahng S; Yoo BC; Paik SW; Koh KC; Lee KT; Lee JK; Lee JH; Choi MS; Lee KH
Photochem Photobiol Sci; 2013 Mar; 12(3):439-45. PubMed ID: 23175171
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
[TBL] [Abstract][Full Text] [Related]
3. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
Fuks D; Bartoli E; Delcenserie R; Yzet T; Celice P; Sabbagh C; Chatelain D; Joly JP; Cheron N; Dupas JL; Regimbeau JM
J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885
[TBL] [Abstract][Full Text] [Related]
4. Chemoembolisation for hepatocellular carcinoma with bile duct invasion: is preprocedural biliary drainage mandatory?
Park J; Kim HC; Lee JH; Cho E; Kim M; Hur S; Jae HJ; Lee M; Chung JW
Eur Radiol; 2018 Apr; 28(4):1540-1550. PubMed ID: 29124380
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma with tumor thrombi in the bile duct.
Wang HJ; Kim JH; Kim JH; Kim WH; Kim MW
Hepatogastroenterology; 1999; 46(28):2495-9. PubMed ID: 10522026
[TBL] [Abstract][Full Text] [Related]
6. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.
Witzigmann H; Berr F; Ringel U; Caca K; Uhlmann D; Schoppmeyer K; Tannapfel A; Wittekind C; Mossner J; Hauss J; Wiedmann M
Ann Surg; 2006 Aug; 244(2):230-9. PubMed ID: 16858185
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.
Nanashima A; Yamaguchi H; Shibasaki S; Ide N; Sawai T; Tsuji T; Hidaka S; Sumida Y; Nakagoe T; Nagayasu T
J Gastroenterol; 2004 Nov; 39(11):1095-101. PubMed ID: 15580404
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.
Tanaka T; Kuzuya T; Ishigami M; Ito T; Ishizu Y; Honda T; Ishikawa T; Fujishiro M
Oncology; 2020; 98(9):621-629. PubMed ID: 32434180
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi.
Satoh S; Ikai I; Honda G; Okabe H; Takeyama O; Yamamoto Y; Yamamoto N; Iimuro Y; Shimahara Y; Yamaoka Y
Surgery; 2000 Nov; 128(5):779-83. PubMed ID: 11056440
[TBL] [Abstract][Full Text] [Related]
10. Surgical results for hepatocellular carcinoma with bile duct invasion: a clinicopathologic comparison between macroscopic and microscopic tumor thrombus.
Esaki M; Shimada K; Sano T; Sakamoto Y; Kosuge T; Ojima H
J Surg Oncol; 2005 Jun; 90(4):226-32. PubMed ID: 15906365
[TBL] [Abstract][Full Text] [Related]
11. Intractable bile leakage after hepatectomy for hepatocellular carcinoma in 359 recent cases.
Sadamori H; Yagi T; Matsuda H; Shinoura S; Umeda Y; Fujiwara T
Dig Surg; 2012; 29(2):149-56. PubMed ID: 22555445
[TBL] [Abstract][Full Text] [Related]
12. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma presenting extrahepatic obstructive jaundice due to bile duct invasion--clinicopathological study of two cases.
Oshima S; Okayasu I; Hatakeyama S
Bull Tokyo Med Dent Univ; 1986 Jun; 33(2):91-7. PubMed ID: 3032469
[TBL] [Abstract][Full Text] [Related]
14. Occult hepatocellular carcinoma: a case report of a special icteric-type hepatoma and literature review.
Chang H; Xu J; Mu Q; Qin C; Zhang Z; Wu T
Eur J Cancer Care (Engl); 2010 Sep; 19(5):690-3. PubMed ID: 19659667
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin.
Wagner A; Kiesslich T; Neureiter D; Friesenbichler P; Puespoek A; Denzer UW; Wolkersdörfer GW; Emmanuel K; Lohse AW; Berr F
Photochem Photobiol Sci; 2013 Jun; 12(6):1065-73. PubMed ID: 23558738
[TBL] [Abstract][Full Text] [Related]
16. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy.
Zoepf T; Jakobs R; Arnold JC; Apel D; Riemann JF
Am J Gastroenterol; 2005 Nov; 100(11):2426-30. PubMed ID: 16279895
[TBL] [Abstract][Full Text] [Related]
17. Technology insight: Photodynamic therapy for cholangiocarcinoma.
Ortner MA; Dorta G
Nat Clin Pract Gastroenterol Hepatol; 2006 Aug; 3(8):459-67. PubMed ID: 16883350
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for cholangiocarcinoma: overview and new developments.
Ortner MA
Curr Opin Gastroenterol; 2009 Sep; 25(5):472-6. PubMed ID: 19550314
[TBL] [Abstract][Full Text] [Related]
19. Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study.
Wagner A; Denzer UW; Neureiter D; Kiesslich T; Puespoeck A; Rauws EA; Emmanuel K; Degenhardt N; Frick U; Beuers U; Lohse AW; Berr F; Wolkersdörfer GW
Hepatology; 2015 Nov; 62(5):1456-65. PubMed ID: 25990106
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of Fospeg, and its impact on cell cycle upon PDT of Huh7 hepatocellular carcinoma cell model.
Sherifa G; Saad Zaghloul MA; Elsayed OF; Rueck A; Steiner R; Abdelaziz AI; Abdel-Kader MH
Photodiagnosis Photodyn Ther; 2013 Feb; 10(1):87-94. PubMed ID: 23465377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
